4Saijonmaa O, Nyman T, Stewen P, et al. Atorvastatin completely inhibits VEGF-induced ACE upregulation in human endothelial cells [J]. Am J Physiol Heart Circ Physiol, 2004, 286(6): H2096 - H2102,
5Sven W, Ulrich L, Kirsten M, et al. Cellular antioxidant effects of atorvatatin in vitro and in vivo[J]. Aterioscler Thromb Vasc Biol,2002, 22: 300-305.
6Seljeflot I, Tonsatd S, Hjermann I, et al. Reduced expression of endothelial cell markers after I year treatment with simvastatin and atorvastatin in patients with coronary heart disease [J]. Atherosclerosis,2002, 162(1): 179-185.
7Walter DH, Ritting K, Bahlmann FH, et al. Statin therapy accelerates reendothelialization: a novel effect involving mobilization and incorporation of bone marrow-derived endothelial progenitor cells [J].Circulation, 2002, 105(25): 3017-3024.
8Kishi T, Hirooka Y, Mukai Y, et al. Atorvastatin causes depressor and sympathoinhibitory effects with upregulation of nitric oxide synthase in stroke-prone spontaneously hypertensive rats [J]. J Hypertens, 2003, 21(2): 379-386.
9Luan Z, Chase AJ, Newby AC. statins inhibit secretion of metalloproteinase-1, - 2, - 3 and - 9 from vascular smooth muscle cells and macrophages[J], Arterioscler Thromb Vasc Biol, 2003, 23(5):769 - 775.
10Gross CM, Gerbaulet S, Quensel S,et al. Agiotensin II type I receptor expression in human coronary arteries with viriable degrees of atheriosclerosis [J]. Basic Res Cardiol, 2002, 97(4): 327-333.
